CN106236879A - A kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium - Google Patents

A kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium Download PDF

Info

Publication number
CN106236879A
CN106236879A CN201610704745.5A CN201610704745A CN106236879A CN 106236879 A CN106236879 A CN 106236879A CN 201610704745 A CN201610704745 A CN 201610704745A CN 106236879 A CN106236879 A CN 106236879A
Authority
CN
China
Prior art keywords
fructus rosae
rosae laevigatae
ceftiofur sodium
compound medicine
poultry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610704745.5A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University
Original Assignee
Guangxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University filed Critical Guangxi University
Priority to CN201610704745.5A priority Critical patent/CN106236879A/en
Publication of CN106236879A publication Critical patent/CN106236879A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738Rosa (rose)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium, be made up of ceftiofur sodium and Fructus Rosae Laevigatae, the weight ratio of ceftiofur sodium and Fructus Rosae Laevigatae is 1:10 1:30.Described ceftiofur sodium and the weight ratio of Fructus Rosae Laevigatae are preferably 1:10.The present invention is also claimed by the compound preparation become prepared by above-mentioned poultry compound medicine.The present invention possesses and provides the benefit that: proving through experimental study, ceftiofur sodium is used in combination with specific part by weight with Fructus Rosae Laevigatae, has synergism obvious, and curative effect is fast, low cost and other advantages.

Description

A kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium
Technical field
The invention belongs to poultry compound medicine technical field, particularly relate to a kind of containing Fructus Rosae Laevigatae with the poultry of ceftiofur sodium Fowl compound medicine, the disease caused for treating poultry to be infected by colon bacillus.
Background technology
After poultry are infected by colon bacillus, the multiple locations such as acute sepsis, peritonitis, hepatitis, pneumonia, enteritis can be caused Severe infections, causes huge economic loss to livestock and poultry cultivation.Ceftiofur sodium, norfloxacin, florfenicol etc. are to prevent and treat this The conventional Western medicine of class disease, along with medication is more and more spread unchecked, its Resistant strain is the most, and drug cost is the most increasing, but It is therapeutic effect and drug resistance situation is not taken a turn for the better, go from bad to worse on the contrary.
Through retrieval, do not inquire and Fructus Rosae Laevigatae and ceftiofur sodium are combined for treating poultry by colon bacillus sense The relevant report of the disease that dye causes.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium, Its synergism is obvious, it is possible to eliminate the colon bacillus drug resistance to ceftiofur sodium, improves therapeutic effect.
For solving above technical problem, the present invention by the following technical solutions: a kind of containing Fructus Rosae Laevigatae and ceftiofur sodium Poultry compound medicine, is made up of ceftiofur sodium and Fructus Rosae Laevigatae, and the weight ratio of ceftiofur sodium and Fructus Rosae Laevigatae is 1:10-1: 30。
Described ceftiofur sodium and the weight ratio of Fructus Rosae Laevigatae are preferably 1:10.
The present invention is also claimed by the compound preparation become prepared by above-mentioned poultry compound medicine.
The present invention possesses and provides the benefit that: prove through experimental study, and ceftiofur sodium and Fructus Rosae Laevigatae are with specific weight Ratio is used in combination, and has synergism obvious, and curative effect is fast, low cost and other advantages.
Detailed description of the invention
Below in conjunction with specific embodiment, technical scheme and beneficial effect are described further, except Special Statement Outward, Fructus Rosae Laevigatae weight of the present invention is the dry weight of Fructus Rosae Laevigatae.
One, the Fructus Rosae Laevigatae mensuration to the drug resistance elimination effect of ceftiofur sodium
1. assay method
It is the mixing that 1:1,1:3,1:5,1:10,1:30,1:50 prepare Fructus Rosae Laevigatae and various Western medicine respectively according to weight ratio Medicinal liquid;Choose the bacterial strain to Western medicine drug resistance as subjects, utilize plate dilution method to carry out Secondary Culture, measure each process medicine The liquid MIC situation of change to Resistant strain;Set the Western medicine being not added with Fructus Rosae Laevigatae to compare as sun, if being not added with Fructus Rosae Laevigatae and Western medicine work simultaneously Compare for the moon.
Above-mentioned process was cultivated for 4 generations the most continuously.
2. result of the test
After cultivating for 4 generations continuously, the process flat board of cloudy comparison is long bacterium, and other each medicaments and admixing medical solutions are for large intestine angstrom The result statistics of the MIC of uncommon Salmonella is as shown in table 1:
As seen from the above table, when the weight ratio of ceftiofur sodium Yu Fructus Rosae Laevigatae is 1:10,1:30, ceftiofur sodium is to drug resistance The minimal inhibitory concentration of colon bacillus reduces 128 times, more than 32 times respectively, it is seen then that drug resistance colon bacillus is to cephalo The drug resistance of ceftiofur sodium substantially reduces.
And when ceftiofur sodium and Fructus Rosae Laevigatae are other weight ratios, ceftiofur sodium is to drug resistance colon bacillus Little Mlc, compared with the sun comparison being not added with Fructus Rosae Laevigatae, does not has significant change.
Two, the experiment in vitro that ceftiofur sodium and Fructus Rosae Laevigatae are used in combination
It is 1:10 mixing by ceftiofur sodium and Fructus Rosae Laevigatae (powder) according to weight ratio, makes powder, as test group;Separately set Ceftiofur sodium single dose and Fructus Rosae Laevigatae single dose as a control group 1 and matched group 2.
Subjects is the chicken group making a definite diagnosis and having infected E.coli from chickens disease.
Morbidity chicken group is divided into 3 groups of administrations.Test group is administered according to the addition of 6g/kg feedstuff, matched group 1 cephalo thiophene Furan sodium single dose is administered according to the addition of 0.5g/kg feedstuff, and matched group 2 uses Fructus Rosae Laevigatae single dose according to the addition of 6g/kg feedstuff It is administered;The equal SM of each group 5 days.
Result of the test: the sick chicken feed intake of test group increased, without dead, after using 5 days, chicken group can fully recover;Comparison Chicken group's great majority still wan of group 1, has the sick chicken death of 5%;Chicken group's great majority of matched group 2 are also still wans, have The sick chicken death of 12%.

Claims (3)

1. one kind contains Fructus Rosae Laevigatae and the poultry compound medicine of ceftiofur sodium, it is characterised in that by ceftiofur sodium and Fructus Rosae Laevigatae Son composition, the weight ratio of ceftiofur sodium and Fructus Rosae Laevigatae is 1:10-1:30.
Poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium the most according to claim 1, it is characterised in that described Ceftiofur sodium and the weight ratio of Fructus Rosae Laevigatae be 1:10.
3. by the compound preparation become prepared by the poultry compound medicine described in claim 1 or 2.
CN201610704745.5A 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium Withdrawn CN106236879A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610704745.5A CN106236879A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610704745.5A CN106236879A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium

Publications (1)

Publication Number Publication Date
CN106236879A true CN106236879A (en) 2016-12-21

Family

ID=57595813

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610704745.5A Withdrawn CN106236879A (en) 2016-08-22 2016-08-22 A kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium

Country Status (1)

Country Link
CN (1) CN106236879A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103989728A (en) * 2014-05-28 2014-08-20 广西大学 Acalypha australis L. and beta-lactam antibacterial medicine containing compound medicine for livestock and poultry

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103989728A (en) * 2014-05-28 2014-08-20 广西大学 Acalypha australis L. and beta-lactam antibacterial medicine containing compound medicine for livestock and poultry

Similar Documents

Publication Publication Date Title
CN106109638A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and LIJUNJING
CN106176897A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and LIJUNJING
CN106138320A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and norfloxacin
CN106138318A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and amoxicillin
CN106109549A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and norfloxacin
CN106236879A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and ceftiofur sodium
CN106139121A (en) A kind of poultry compound medicine containing Cortex Cinnamomi, Fructus Rosae Laevigatae and colistin
CN106138319A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and florfenicol
CN106214742A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and ceftiofur sodium
CN106109548A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and florfenicol
CN106176942A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and norfloxacin
CN106176943A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and LIJUNJING
CN106176941A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and florfenicol
CN106267153A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and colistin
CN106728479A (en) A kind of livestock and poultry compound medicine containing treebine stem and LIJUNJING
CN106166184A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and amikacin
CN106109577A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and sulfamonomethoxine sodium
CN106109547A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and fosfomycin
CN106176896A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and amikacin
CN106176895A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and amoxicillin
CN106266049A (en) A kind of poultry compound medicine containing Fructus Rosae Laevigatae and sulfamonomethoxine sodium
CN106109578A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and amoxicillin
CN106267152A (en) A kind of poultry compound medicine containing Herba Euphorbiae Humifusae and colistin
CN106166176A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and fosfomycin
CN106177904A (en) A kind of poultry compound medicine containing Cortex Cinnamomi and colistin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20161221